Cobolimab

Overview

Cobolimab is under investigation in clinical trial NCT04655976 (Study of Cobolimab in Combination With Dostarlimab and Docetaxel in Advanced NSCLC Participants).

Background

Cobolimab is under investigation in clinical trial NCT04655976 (Study of Cobolimab in Combination With Dostarlimab and Docetaxel in Advanced NSCLC Participants).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title	Posted	Study ID	Phase	Status	Sponsor
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer	2024/07/26	NCT06521567	Phase 1	Recruiting	GlaxoSmithKline
Dostarlimab and Cobolimab in Advanced Cervical Cancer	2024/02/02	NCT06238635	Phase 2	Recruiting	Meghan Shea
Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed on Prior Anti-PD-(L)1 Therapy and Chemotherapy	2020/12/07	NCT04655976	Phase 3	Active, not recruiting	GlaxoSmithKline
Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid Tumors	2020/06/24	NCT04446351	Phase 1	Active, not recruiting	GlaxoSmithKline
Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042	2017/10/12	NCT03307785	Phase 1	Active, not recruiting	Tesaro, Inc.
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)	2016/06/29	NCT02817633	Phase 1	Recruiting	Tesaro, Inc.
Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)	2016/03/31	NCT02723955	Phase 1	Completed	GlaxoSmithKline

FDA Drug Approvals

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
No TGA approvals found for this drug.

AI-Powered Research

Premium Access